CCL2 and COVID-19: In Chinese patients, a study showed that COVID-19 patients had increased concentrations of interleukin (IL) 1B, interferon (IFN) γ, interferon gamma-induced protein 10 (IP10), and monocyte chemoattractant protein 1 (MCP1) [2].